The national law firm of Parker Waichman LLP has filed a lawsuit on behalf of a Virginia man who claims he developed bladder cancer after taking the diabetes drug Actos. The lawsuit was filed in the U.S. District Court for the Western District of Louisiana against pharmaceutical drug maker Takeda. The lawsuit joins pending multidistrict litigation proceedings under Judge Rebecca F. Doherty. Jerrold S. Parker, co-founder of Parker Waichman has been appointed to the Plaintiffs’ Steering Committee.
The lawsuit alleges the plaintiff took the drug from 2006 to 2011 before he developed bladder cancer. The lawsuit also alleges that Takeda failed to warn consumers that taking Actos for an extended period of time increases the risk of bladder cancer. The complaint says the plaintiff would not have used the drug if he had known of those risks. According to the lawsuit, the defendants have yet to alert customers of the increased risk of bladder cancer when using the drug for more than one year.
The FDA warned about the increased risk of bladder cancer last June, saying that patients taking Actos for more than one year were 40 percent more likely to develop bladder cancer and that the risk increased with dosage.
The lawsuit seeks damages for severe mental and physical pain and suffering, past and future permanent injuries and emotional distress, economic loss due to medical expenses, living related expenses as a result of having to live with bladder cancer, and loss of consortium.